Developer docs
API playgroundTry for free, no card

Search company profiles

SpringTide Ventures

Full company profile

uuid0003nli

Namestring
SpringTide Ventures
Legal namestring
SpringTide Ventures
Websiteurl
springtide.com
Company typeenum
Private
Founded yearint
2018
Descriptiontext

SpringTide Ventures is an early-stage healthcare technology venture capital firm founded in 2018 and headquartered in Cambridge, Massachusetts, with additional offices in Boston, Salt Lake City, and San Francisco. The firm leads seed and Series A financings for digital health, telehealth, remote patient monitoring, behavioral health, reproductive medicine, obesity treatment, and primary care startups. Its core operational model is direct investment: SpringTide writes checks into portfolio companies and provides strategic support through follow-on funding facilitation and introductions to its network of 114 investors, 22 venture partners, and 10 technology partners who provide local coverage of health-tech innovation hotspots.

The firm supports founders beyond capital deployment through the WAVE Summit and Labs program, a branded healthcare innovation community that convenes entrepreneurs, clinicians, investors, and policymakers to discuss commercialization of digital health innovations. SpringTide's go-to-market relies on thesis-driven sourcing and lead-investor positioning rather than passive fund participation; the team actively publishes thought leadership content on health insurtech, AI in healthcare, and clinical trials, and partners with institutions such as Cincinnati Children's for pipeline development. The firm does not operate a product or technology platform of its own, and its competitive differentiation is rooted in network reach and sector specialization rather than proprietary tooling.

SpringTide's revenue model follows standard VC economics, combining management fees on managed funds with carried interest from successful portfolio exits. The firm has demonstrated exit execution with PathologyWatch's $150M acquisition by Sonic Healthcare in December 2023, alongside ongoing portfolio growth across companies such as OpenLoop (telehealth infrastructure), Tenovi (remote patient monitoring), Tava Health (behavioral health), FlyteHealth (obesity medicine), and Nest Health (in-home family primary care). The core team consists of approximately eight professionals led by Managing Partner Austin Walters.

Short descriptiontext

SpringTide Ventures is a US-based early-stage venture capital firm founded in 2018 that leads financings for healthcare technology startups across telehealth, remote patient monitoring, behavioral health, and primary care, supporting founders through capital, a 146-partner network, and the WAVE Summit program.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSalt Lake City, United States
HQ citystring
Salt Lake City
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare venture capital, early-stage health investing, digital health funding, seed and series A investing, health-tech startup financing
Industry4 codes
PRIMARYFSANAAAB
Early-Stage Venture Capital (Series A/B)
SECONDARYFSANAAAA
Early-Stage Venture Capital (Pre-Seed/Seed)
SECONDARYFSANAAAC
Late-Stage Venture Capital (Series C+)
SECONDARYFSANAJAI
Healthcare Access & Life Sciences Impact Funds
Financial & Insurance/Private Equity & Venture Capital/Impact / ESG & Sustainable Investment Funds
NAICS code1 code
  • Funds, Trusts, and Other Financial Vehicles525
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital (Healthcare Technology)
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Venture Capital Returns
TypeTransaction Fee
Description

SpringTide generates returns through management fees on managed funds and carried interest (carry) from successful portfolio company exits. As an early-stage investor in healthcare technology companies, their revenue model is based on equity appreciation from their portfolio investments.

springtide.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

SpringTide Ventures leads early-stage financings for healthcare technology companies, providing venture capital and strategic support to founders building digital health solutions. The firm also operates the WAVE program, which brings together healthcare innovators, entrepreneurs, and investors through summits and labs to advance digital health collaboration and policy.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • PathologyWatch acquired for $150M by Sonic Healthcare, demonstrating successful exit execution
+4 more records
Product overview1 text field

SpringTide Ventures is a venture capital firm focused exclusively on early-stage healthcare technology investments. The firm leads financings for healthcare companies and provides portfolio support through its network of investors, venture partners, and technology partners. Its primary offerings include investment capital for founders and the WAVE program, which connects healthcare innovators through summits and labs to advance digital health solutions.

Product and service2 records
1Investment Services
CategoryVenture Capital / Investment Service
Description

Lead-investor early-stage venture capital financing for healthcare technology companies, providing capital and strategic support to founders across seed, Series A, and later rounds.

2WAVE Summit and Labs
CategoryProgram / Event Platform
Description

Healthcare innovation summits and labs program that convenes entrepreneurs, investors, and healthcare innovators to foster collaboration, advance innovative technology, and drive policy to enhance care delivery globally.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierMinorTypeStrategic or Co-development Partner
Description

SpringTide portfolio Nest Health operates in context of March of Dimes data showing Louisiana received 'F' grade for maternal and infant health.

Strategic tierMinorTypeOthers
Description

SpringTide portfolio Vytalize Health references AAMC data on physician shortage projections in their value proposition materials.

3BlueJeans by Verizon
Strategic tierCoreTypeStrategic or Co-development Partner
Description

OpenLoop Health (SpringTide portfolio) partnered with BlueJeans by Verizon to expand access to quality virtual visits through a HIPAA-ready telehealth platform combined with OpenLoop's nationwide clinician network.

springtide.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

OpenLoop provides telehealth infrastructure for Grindr's Woodwork service targeting LGBTQ+ audiences with licensed clinicians and inclusive care.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Tenovi (SpringTide portfolio) partnered with Truentity Health to distribute RPM devices through independent pharmacies nationwide.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Tenovi partnered with Nonin Medical for strategic integration focused on advancing health equity for chronic care patients through remote monitoring.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Tenovi partnered with Trividia Health to reduce total cost of diabetes care through streamlined glucose monitoring solutions.

Strategic tierCoreTypeTechnology or Integration
Description

Great Expectations (SpringTide portfolio) protects Komodo Health's complex data pipelines processing 15M+ clinical encounters daily and 320M+ patient records.

9Imaging Panda
Strategic tierMinorTypeOthers
Description

OpenLoop Health (SpringTide portfolio) acquired Imaging Panda to expand diagnostic imaging support services into their telehealth platform.

springtide.com
Strategic tierMinorTypeOthers
Description

OpenLoop Health achieved SOC 2 Type 1 certification in late 2024, demonstrating commitment to security and compliance standards.

Strategic tierMinorTypeOthers
Description

OpenLoop Health received LegitScript Healthcare Merchant Certification, the global standard for monitoring and certifying high-risk healthcare products and services.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers11 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment46 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SpringTide Ventures

Venture Capital (Healthcare Technology)springtide.com

SpringTide Ventures is a US-based early-stage venture capital firm founded in 2018 that leads financings for healthcare technology startups across telehealth, remote patient monitoring, behavioral health, and primary care, supporting founders through capital, a 146-partner network, and the WAVE Summit program.

What SpringTide Ventures does

SpringTide Ventures is an early-stage healthcare technology venture capital firm founded in 2018 and headquartered in Cambridge, Massachusetts, with additional offices in Boston, Salt Lake City, and San Francisco. The firm leads seed and Series A financings for digital health, telehealth, remote patient monitoring, behavioral health, reproductive medicine, obesity treatment, and primary care startups. Its core operational model is direct investment: SpringTide writes checks into portfolio companies and provides strategic support through follow-on funding facilitation and introductions to its network of 114 investors, 22 venture partners, and 10 technology partners who provide local coverage of health-tech innovation hotspots.

The firm supports founders beyond capital deployment through the WAVE Summit and Labs program, a branded healthcare innovation community that convenes entrepreneurs, clinicians, investors, and policymakers to discuss commercialization of digital health innovations. SpringTide's go-to-market relies on thesis-driven sourcing and lead-investor positioning rather than passive fund participation; the team actively publishes thought leadership content on health insurtech, AI in healthcare, and clinical trials, and partners with institutions such as Cincinnati Children's for pipeline development. The firm does not operate a product or technology platform of its own, and its competitive differentiation is rooted in network reach and sector specialization rather than proprietary tooling.

SpringTide's revenue model follows standard VC economics, combining management fees on managed funds with carried interest from successful portfolio exits. The firm has demonstrated exit execution with PathologyWatch's $150M acquisition by Sonic Healthcare in December 2023, alongside ongoing portfolio growth across companies such as OpenLoop (telehealth infrastructure), Tenovi (remote patient monitoring), Tava Health (behavioral health), FlyteHealth (obesity medicine), and Nest Health (in-home family primary care). The core team consists of approximately eight professionals led by Managing Partner Austin Walters.

SpringTide Ventures firmographics

Firmographics
Name
SpringTide Ventures
Legal name
SpringTide Ventures
Website
https://springtide.com
Company type
Private
Founded year
2018
Operating status
Operating
Headcount range
11–50 employees
Short description
SpringTide Ventures is a US-based early-stage venture capital firm founded in 2018 that leads financings for healthcare technology startups across telehealth, remote patient monitoring, behavioral health, and primary care, supporting founders through capital, a 146-partner network, and the WAVE Summit program.
Ownership category
akta.pro rank

SpringTide Ventures industry classification

Industry
Product category
Venture Capital (Healthcare Technology)
NAICS
Funds, Trusts, and Other Financial Vehicles (525)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAAAB
Early-Stage Venture Capital (Series A/B)
SECONDARYFSANAAAA
Early-Stage Venture Capital (Pre-Seed/Seed)
SECONDARYFSANAAAC
Late-Stage Venture Capital (Series C+)
SECONDARYFSANAJAI
Healthcare Access & Life Sciences Impact Funds
Financial & Insurance/Private Equity & Venture Capital/Impact / ESG & Sustainable Investment Funds

Keywords

  • Healthcare venture capital
  • Early-stage health investing
  • Digital health funding
  • Seed and series A investing
  • Health-tech startup financing

Where SpringTide Ventures is headquartered

Location

Headquarters

HQ city
Salt Lake City
HQ country
United States
HQ region
North America

Offices3 records

Markets served

SpringTide Ventures business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Venture Capital Returns: SpringTide generates returns through management fees on managed funds and carried interest (carry) from successful portfolio company exits. As an early-stage investor in healthcare technology companies, their revenue model is based on equity appreciation from their portfolio investments.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

SpringTide Ventures product offering

Product offering

Core offering

SpringTide Ventures leads early-stage financings for healthcare technology companies, providing venture capital and strategic support to founders building digital health solutions. The firm also operates the WAVE program, which brings together healthcare innovators, entrepreneurs, and investors through summits and labs to advance digital health collaboration and policy.

Product overview

SpringTide Ventures is a venture capital firm focused exclusively on early-stage healthcare technology investments. The firm leads financings for healthcare companies and provides portfolio support through its network of investors, venture partners, and technology partners. Its primary offerings include investment capital for founders and the WAVE program, which connects healthcare innovators through summits and labs to advance digital health solutions.

Differentiator

Problem solved

Functional benefit

Products and services

  • Investment Services Lead-investor early-stage venture capital financing for healthcare technology companies, providing capital and strategic support to founders across seed, Series A, and later rounds.
  • WAVE Summit and Labs Healthcare innovation summits and labs program that convenes entrepreneurs, investors, and healthcare innovators to foster collaboration, advance innovative technology, and drive policy to enhance care delivery globally.

Quantifiable outcome

  • PathologyWatch acquired for $150M by Sonic Healthcare, demonstrating successful exit execution
  • +4 more outcomes

Companies that use SpringTide Ventures

Customer profile

Named customers11 records

Segments2 records

Ideal customer profiles1 record

SpringTide Ventures technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

SpringTide Ventures partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered minor and core.

  • March of DimesminorStrategic or Co-development PartnerSpringTide portfolio Nest Health operates in context of March of Dimes data showing Louisiana received 'F' grade for maternal and infant health.
  • Association of American Medical CollegesminorOthersSpringTide portfolio Vytalize Health references AAMC data on physician shortage projections in their value proposition materials.
  • BlueJeans by VerizoncoreStrategic or Co-development PartnerOpenLoop Health (SpringTide portfolio) partnered with BlueJeans by Verizon to expand access to quality virtual visits through a HIPAA-ready telehealth platform combined with OpenLoop's nationwide clinician network.
  • Grindr (Woodwork)minorChannel Partner/ Reseller/ DistributorOpenLoop provides telehealth infrastructure for Grindr's Woodwork service targeting LGBTQ+ audiences with licensed clinicians and inclusive care.
  • Truentity HealthcoreStrategic or Co-development PartnerTenovi (SpringTide portfolio) partnered with Truentity Health to distribute RPM devices through independent pharmacies nationwide.
  • Nonin MedicalminorStrategic or Co-development PartnerTenovi partnered with Nonin Medical for strategic integration focused on advancing health equity for chronic care patients through remote monitoring.
  • Trividia HealthminorStrategic or Co-development PartnerTenovi partnered with Trividia Health to reduce total cost of diabetes care through streamlined glucose monitoring solutions.
  • Komodo HealthcoreTechnology or IntegrationGreat Expectations (SpringTide portfolio) protects Komodo Health's complex data pipelines processing 15M+ clinical encounters daily and 320M+ patient records.
  • Imaging PandaminorOthersOpenLoop Health (SpringTide portfolio) acquired Imaging Panda to expand diagnostic imaging support services into their telehealth platform.
  • SOC 2 Type 1 CertifiedminorOthersOpenLoop Health achieved SOC 2 Type 1 certification in late 2024, demonstrating commitment to security and compliance standards.
  • LegitScript CertifiedminorOthersOpenLoop Health received LegitScript Healthcare Merchant Certification, the global standard for monitoring and certifying high-risk healthcare products and services.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

SpringTide Ventures competitors and assessment

Company assessment

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

SpringTide Ventures social profiles

Digital presence

SpringTide Ventures financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SpringTide Ventures leadership team

Management profile

Number of profiles

Profiles12 records

SpringTide Ventures funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SpringTide Ventures M&A and investment

M&A and investment

M&A

Investments46 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SpringTide Ventures

What does SpringTide Ventures do?

SpringTide Ventures leads early-stage financings for healthcare technology companies, providing venture capital and strategic support to founders building digital health solutions. The firm also operates the WAVE program, which brings together healthcare innovators, entrepreneurs, and investors through summits and labs to advance digital health collaboration and policy.

Is SpringTide Ventures a public or private company?

SpringTide Ventures is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was SpringTide Ventures founded?

SpringTide Ventures was founded in 2018. It employs 11 to 50 people.

Where is SpringTide Ventures based?

SpringTide Ventures is headquartered in Salt Lake City, United States, in the North America region.

How does SpringTide Ventures make money?

One revenue line is on record: venture Capital Returns.

Does SpringTide Ventures have an API?

No public API is recorded for SpringTide Ventures.

What industry is SpringTide Ventures in?

SpringTide Ventures's product category is Venture Capital (Healthcare Technology). Its primary akta.pro industry code is FSANAAAB, Early-Stage Venture Capital (Series A/B), with a secondary code of FSANAAAA, Early-Stage Venture Capital (Pre-Seed/Seed). Its NAICS code is 525 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
MassDeviceRemote ultrasound robot developer Dopl raises $6M seed roundDopl Technologies, a Bothell, Washington-based medical device startup, closed a $6.3 million seed round led by SpringTide Ventures to advance its remote robotic ultrasound technology, bringing total funding to over $8 million. The company, which has 10 employees and was part of the 2024 Medtech Innovator cohort, plans to submit its Traverse remote robotic ultrasound system for FDA 510(k) review in 2027, with design freeze expected in the coming months. The funding will support product verification, validation, regulatory clearance, clinical evaluation, and initial market release, as the company targets the estimated $40 billion annual reimbursement opportunity for telerobotic imaging in U.S. hospitals.The SaaS NewsTava Health Raises $40M Series CTava Health, a Salt Lake City-based behavioral health technology company, raised $40 million in Series C funding led by Centana Growth Partners. The company will use the funds to invest in platform infrastructure, AI-powered tools, and support clinicians, employers, and health plans. Tava Health integrates with over 200 health plans across all 50 states.Venture Capital Access OnlineTava Health Raises $40M Series C, Led by Centana Growth PartnersTava Health raised $40 million in a Series C round led by Centana Growth Partners, with participation from current investors. The funding supports new offerings including an AI-powered clinic operating system, a zero-budget employer benefit, and a care-navigation suite. The company already reaches nine in 10 commercially insured Americans through integrations with over 200 health plans.FinSMEsTava Health Raises $40M in Series C FundingTava Health raised $40M in Series C funding led by Centana Growth Partners, with participation from Catalyst Investors, Blue Heron Ventures, Peterson Ventures, and Springtide Ventures. The company will use the funds to expand operations and development, and its services reach nine in 10 commercially insured Americans through integrations with over 200 health plans.Venture Capital Access OnlineWellsheet Raises Series A Funding for Healthcare Workflow Platform to Reduce Time in the EHR and Physician BurnoutWellsheet Inc. announced a $3.8 million Series A funding round led by SpringTide Investments, with participation from BioAdvance and Newark Venture Partners. The company plans to utilize the capital to expand its engineering and go-to-market teams while extending its AI-powered platform designed to optimize Electronic Health Record (EHR) workflows for health systems.CincinnatichildrensHow to Accelerate Digital Health InnovationsInvestors from SpringTide Ventures discussed strategies for successfully commercializing digital health innovations with Cincinnati Children’s innovators. Key points included the importance of evidence collection, strategic funding, and team strength in investment decisions. The article highlights the value of Cincinnati Children's extensive professional network in supporting health tech startups.PaternabioPaterna Secures $6M Seed Funding for Male infertilityPaterna BioSciences closed a $6 million oversubscribed seed round led by SpringTide Ventures to advance its in vitro spermatogenesis technology for male infertility. The funding will support preclinical development and early-phase studies expected in 2025, with market entry after FDA approval.American City Business JournalsTop Boston VC firms that have raised money in 2024Twelve Boston-area venture capital firms have fresh capital in 2024, down from over 15 last year. The firms include One Way Ventures raising $60 million, Glasswing Ventures planning $150 million, and Breakthrough Energy Ventures raising $555 million. The list also covers firms like SpringTide, Underscore, and Alumni Ventures.YahooSpringTide Ventures Announces the Close of $65 Million Fund IISpringTide Ventures closed its Fund II at $65 million, bringing total assets under management to over $100 million. The firm will use the capital to invest in digital health, medical devices, life sciences, and tech-enabled care delivery. The announcement highlights portfolio achievements, including Pathology Watch's $150 million acquisition and OpenLoop's $100 million annualized revenue.Business Wire BlogSpringTide Ventures Announces the Close of $65 Million Fund IISpringTide Ventures closed its Fund II at $65 million, bringing total assets under management to over $100 million. The firm will use the capital to invest in startups in digital health, medical devices, life sciences, and tech-enabled care delivery. The announcement highlights portfolio achievements, including a dermatopathology platform acquired for $150 million.